Published December 20, 2022 | Version v1

Protective efficacy of anti-Hyr1p monoclonal antibody against systemic candidiasis due to multi-drug resistant Candida au-ris

  • 1. Division of Infectious Diseases, The Lundquist Institute for Biomedical Innovation at Harbor-University of Cal-ifornia at Los Angeles (UCLA) Medical Center, Torrance, CA, U.S.A

Description

Supplementary Data

Files

Supplementary Material.pdf

Files (339.2 kB)

Name Size
md5:ac34b9b38a64a1ae5082cf13d620cfec
339.2 kB Preview Download

Additional details

Funding

National Institutes of Health
Cross-Kingdom Vaccine Targeting Healthcare-Associated Priority Pathogens 1R01AI141202-01